Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 16.95
-0.10 (-0.59%)
At close: Aug 28, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 13.65 billion as of August 28, 2026. Its market cap has decreased by -32.57% in one year.
Market Cap
13.65B
Enterprise Value
8.51B
Revenue
2.19B
Ranking
n/a
PE Ratio
30.78
Stock Price
16.95
ChartMarket Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 13.65B, an increase of 27.84%. That is a compound annual growth rate of 14.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 13.65B | -6.09% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lian Hwa Foods | 26.46B |
| Standard Foods | 26.03B |
| TTET Union | 25.04B |
| Ve Wong | 10.74B |
| Tehmag Foods | 9.34B |
| Microbio | 9.00B |
| Namchow Holdings | 8.13B |
| Taisun Enterprise | 7.08B |